Device / Technology News

RSS

Positive outcomes from Boston Scientific's Epic Stent trial on iliac artery disease

Boston Scientific Corporation reports nine-month clinical endpoint data from its ORION trial, demonstrating excellent outcomes for the Company's Epic Self-Expanding Nitinol Stent System in patients with iliac artery disease, a form of peripheral artery disease associated with severe leg pain caused by insufficient blood flow.

16 Jan 2012

AxoGen reports results from Avance Nerve Graft clinical study on PNI

AxoGen, Inc., an emerging regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today reported the publication of peer-reviewed clinical research conducted at twelve leading US surgical sites and led by the Buncke Clinic in San Francisco.

16 Jan 2012

ForSight VISION4 to receive first milestone payment for Lucentis drug delivery device

Genentech, a member of the Roche Group, today announced it will make its first milestone payment to ForSight VISION4, Inc. as part of an exclusive license agreement to develop the company's investigational drug delivery device, designed to provide sustained delivery of Lucentis (ranibizumab).

13 Jan 2012

Improving obstetric care with solar power

In the National Geographic News blog "Mobile Message," "a series of posts from FrontlineSMS about how mobile phones and appropriate technologies are being used throughout the world to improve, enrich, and empower billions of lives," Laura Stachel, an obstetrician-gynecologist and the co-founder and executive director of WE CARE Solar, writes about the "'Solar Suitcase,' a portable, rugged, complete solar electric kit packed with solar panels, a charge controller, batteries, medical LED lights, phone chargers, headlamps, and a fetal monitor."

13 Jan 2012

Agilux implements Thermo Watson LIMS for bioanalytical services

Agilux Laboratories, a provider of pharmaceutical and biotech services, today announced that it has completed the validation and implementation of the Thermo Watson Laboratory Information Management System (LIMS) for the company's bioanalytical services.

13 Jan 2012

Governors' agendas include Medicaid but not much on state insurance exchanges

Meanwhile, a Colorado legislator seeks to force the governor to ask for a waiver to change the Medicaid program.

13 Jan 2012

U.S. Army working to bring virtual health care to Albanian hospitals

The U.S. Army in a news article on its website reports on how it is working to "bring virtual health care to Albanian hospitals" through a telemedicine program that "aims to link different levels of health care to ensure a better functioning and sustainable system."

13 Jan 2012

IBM's non-contact, microfluidic, silicon probe minimizes patient discomfort

IBM scientists have developed a flexible, non-contact microfluidic probe made from silicon that can aid researchers and pathologists to investigate critical tissue samples accurately for drug discovery and disease diagnostics.

13 Jan 2012

NimbleGen Sequence Capture 385K array identifies gene mutations linked with hereditary hearing loss

Hereditary hearing loss is the most common sensory disorder in humans. A German research team led by Ingo Kurth from the Institute of Human Genetics at the University Hospital Jena, Germany, used a number of different methods, including Roche's NimbleGen Custom Sequence Capture 385K array to identify the gene mutated in the disease locus of the X-chromosome of a Spanish family with hereditary hearing loss.

13 Jan 2012

Smart injectable nanotherapeutics could improve treatment for Type I diabetes

A research collaboration between the Wyss Institute for Biologically Inspired Engineering at Harvard University and Children's Hospital Boston has developed "smart" injectable nanotherapeutics that can be programmed to selectively deliver drugs to the cells of the pancreas. Although this nanotechnology will need significant additional testing and development before being ready for clinical use, it could potentially improve treatment for Type I diabetes by increasing therapeutic efficacy and reducing side effects.

13 Jan 2012

Cryo-electron microscopy can visualize structures within viruses

Since the discovery of the microscope, scientists have tried to visualize smaller and smaller structures to provide insights into the inner workings of human cells, bacteria and viruses. Now, researchers at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health, have developed a new way to see structures within viruses that were not clearly seen before.

13 Jan 2012

Heart bracelet system could prevent cases of sports-related sudden death

The use of heart bracelets connected via ICT to a system of tracking and monitoring could prevent cases of sudden death in sports activities.

13 Jan 2012

New lab test quickly identifies bacterium responsible for staph infections

Researchers from the Georgia Institute of Technology and the Centers for Disease Control and Prevention (CDC) have developed a new laboratory test that can rapidly identify the bacterium responsible for staph infections. This new test takes advantage of unique isotopic labeling combined with specific bacteriophage amplification to rapidly identify Staphylococcus aureus.

13 Jan 2012

New imaging probes can non-invasively detect breast cancer lymph node metastasis

Using two cell surface markers found to be highly expressed in breast cancer lymph node metastasis, researchers at Moffitt Cancer Center, working with colleagues at other institutions, have developed targeted, fluorescent molecular imaging probes that can non-invasively detect breast cancer lymph node metastasis.

13 Jan 2012

Processed nerve allograft effective in treating PNI

In the first-ever multicenter clinical trial on processed nerve allograft, researchers from The Buncke Clinic in San Francisco found that treatment of severed peripheral nerve with processed nerve allograft showed meaningful recovery in 87 percent of patients, comparing favorably to traditional nerve repair.

13 Jan 2012

SIA recognizes UBM Medica's CancerNetwork with Summit EMA

UBM Medica today announced that CancerNetwork has been recognized by the Summit International Awards (SIA) with a Summit Emerging Media Award (Summit EMA) for being a leader in advertising through the use of innovative digital technologies.

13 Jan 2012

Clinical trial to compare Aria's prenatal test and standard first-trimester screening for T21

Aria Diagnostics, a molecular diagnostics company, announced that it is initiating a blinded, multicenter clinical trial that compares its non-invasive prenatal test with the standard first-trimester screening test (serum screening and nuchal translucency ultrasound alone and in combination) to detect Trisomy 21, which is associated with Down syndrome.

13 Jan 2012

UBM Medica announces unique marketing and distribution partnership with HITECH Answers

HITECH Answers, a leading provider of educational resources on the HITECH Act, the ARRA stimulus benefits and Meaningful Use (MU) announced today a unique marketing and distribution partnership with UBM Medica.

13 Jan 2012

Ocular drug delivery: DSM awarded membership in PANOPTES EU Funded Consortium

DSM, a global leader in biomedical materials sciences, today announced that it is contributing proprietary knowledge in the preparation of tailored amino acid-based polymers and offering use of processing facilities that will produce an innovative step change in the sustained delivery of drug molecules. The PANOPTES consortium’s goal is to research and develop novel drug delivery technology for the posterior eye segment. This partnership further validates the innovative properties of DSM’s polyesteramide (PEA) biomaterials as a superior drug delivery technology.

12 Jan 2012

Aerocrine's NIOX MINO receives market approvals in Taiwan, South Korea

Aerocrine announced that it's product, NIOX MINO, has received market approvals on the South Korean and Taiwanese markets. An approval is an important step towards receiving reimbursement for inflammation monitoring with the help of FeNO in asthma management.

12 Jan 2012